These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24658683)

  • 1. Evaluation of cardiac sympathetic nerve activity and aldosterone suppression in patients with acute decompensated heart failure on treatment containing intravenous atrial natriuretic peptide.
    Kasama S; Toyama T; Iwasaki T; Sumino H; Kumakura H; Minami K; Ichikawa S; Matsumoto N; Nakata T; Kurabayashi M
    Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1683-91. PubMed ID: 24658683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ishikawa T; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Jul; 45(7):1108-13. PubMed ID: 15235055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity and left ventricular remodeling in patients with first anterior acute myocardial infarction.
    Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Am Coll Cardiol; 2007 Feb; 49(6):667-74. PubMed ID: 17291931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.
    Kasama S; Toyama T; Sumino H; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2007 Dec; 48(12):1993-2000. PubMed ID: 18006623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adding intravenous nicorandil to standard therapy on cardiac sympathetic nerve activity and myocyte dysfunction in patients with acute decompensated heart failure.
    Kasama S; Toyama T; Funada R; Takama N; Koitabashi N; Ichikawa S; Suzuki Y; Matsumoto N; Sato Y; Kurabayashi M
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):761-70. PubMed ID: 25634117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of statin therapy on cardiac sympathetic nerve activity and left ventricular remodeling in patients with chronic heart failure: a propensity score-matched analysis.
    Sano H; Kasama S; Fujimoto S; Toyama T; Takama N; Koitabashi N; Ichikawa S; Suzuki Y; Matsumoto N; Sato Y; Kurabayashi M
    Medicine (Baltimore); 2014 Dec; 93(27):e214. PubMed ID: 25501081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):964-71. PubMed ID: 15803314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral nicorandil therapy on sympathetic nerve activity and cardiac events in patients with chronic heart failure: subanalysis of our previous report using propensity score matching.
    Kasama S; Toyama T; Iwasaki T; Sumino H; Kumakura H; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
    Eur J Nucl Med Mol Imaging; 2014 Jan; 41(1):144-54. PubMed ID: 23982455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP].
    Yahara Y; Nomura Y; Okamoto S; Saitou K; Okamoto R; Makino K; Aoki S; Takeda K
    Kaku Igaku; 2000 May; 37(3):217-25. PubMed ID: 10860352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Am Coll Cardiol; 2005 Mar; 45(5):661-7. PubMed ID: 15734608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
    Shinohara H; Fukuda N; Soeki T; Sakabe K; Onose Y; Tamura Y
    Heart Vessels; 2002 Dec; 17(2):47-52. PubMed ID: 12541093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
    Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Eur Heart J; 2007 Apr; 28(8):989-95. PubMed ID: 17409109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure.
    Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Heart; 2006 May; 92(5):625-30. PubMed ID: 16159967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of therapeutic effects of statin on cardiac sympathetic nerve activity and cardiac events in patients with ischemic cardiomyopathy and mild to moderate heart failure.
    Kasama S; Toyama T; Suzuki S; Ito Y; Matsumoto N; Kurabayashi M; Kasahara M
    Nucl Med Commun; 2019 Feb; 40(2):159-168. PubMed ID: 30461696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of sympathetic nerve activity in end-stage cardiomyopathy patients receiving left ventricular support.
    Miyagawa S; Sawa Y; Fukushima N; Nishimura M; Matsumiya G; Taketani S; Horiguchi K; Ohtake S; Matsuda H
    J Heart Lung Transplant; 2001 Nov; 20(11):1181-7. PubMed ID: 11704478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial sympathetic innervation and long-term left ventricular mechanical unloading.
    Drakos SG; Athanasoulis T; Malliaras KG; Terrovitis JV; Diakos N; Koudoumas D; Ntalianis AS; Theodoropoulos SP; Yacoub MH; Nanas JN
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):64-70. PubMed ID: 20129533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy.
    Simmons WW; Freeman MR; Grima EA; Hsia TW; Armstrong PW
    Circulation; 1994 Jun; 89(6):2843-51. PubMed ID: 8205700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between late ventricular potentials and myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with dilated cardiomyopathy with mild to moderate heart failure: results of a prospective study of sudden death events.
    Kasama S; Toyama T; Kaneko Y; Iwasaki T; Sumino H; Kumakura H; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
    Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1056-64. PubMed ID: 22415599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal iodine
    Okabe Y; Murai H; Tokuhisa H; Hamaoka T; Mukai Y; Sugimoto H; Takashima SI; Kato T; Matsuo S; Usui S; Furusho H; Takamura M; Kaneko S
    Auton Neurosci; 2020 Jul; 226():102671. PubMed ID: 32272358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mineralocorticoid receptor antagonist eplerenone on cardiac sympathetic nerve activity and left ventricular remodeling after reperfusion therapy in patients with first ST-segment elevation myocardial infarction.
    Toda K; Kasama S; Toyama T; Kasahara M; Kurabayashi M
    J Nucl Cardiol; 2022 Oct; 29(5):2325-2335. PubMed ID: 34272676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.